Cite
Clinically relevant inflammatory breast cancer patient-derived xenograft–derived ex vivo model for evaluation of tumor-specific therapies.
MLA
Eckhardt, Bedrich L., et al. “Clinically Relevant Inflammatory Breast Cancer Patient-Derived Xenograft–derived Ex Vivo Model for Evaluation of Tumor-Specific Therapies.” PLoS ONE, vol. 13, no. 5, May 2018, pp. 1–23. EBSCOhost, https://doi.org/10.1371/journal.pone.0195932.
APA
Eckhardt, B. L., Gagliardi, M., Iles, L., Evans, K., Ivan, C., Liu, X., Liu, C.-G., Souza, G., Rao, A., Meric-Bernstam, F., Ueno, N. T., & Bartholomeusz, G. A. (2018). Clinically relevant inflammatory breast cancer patient-derived xenograft–derived ex vivo model for evaluation of tumor-specific therapies. PLoS ONE, 13(5), 1–23. https://doi.org/10.1371/journal.pone.0195932
Chicago
Eckhardt, Bedrich L., Maria Gagliardi, LaKesla Iles, Kurt Evans, Cristina Ivan, Xiuping Liu, Chang-Gong Liu, et al. 2018. “Clinically Relevant Inflammatory Breast Cancer Patient-Derived Xenograft–derived Ex Vivo Model for Evaluation of Tumor-Specific Therapies.” PLoS ONE 13 (5): 1–23. doi:10.1371/journal.pone.0195932.